284 related articles for article (PubMed ID: 21343374)
1. Placental growth factor upregulation is a host response to antiangiogenic therapy.
Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA
Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374
[TBL] [Abstract][Full Text] [Related]
2. sFLT01: a novel fusion protein with antiangiogenic activity.
Bagley RG; Kurtzberg L; Weber W; Nguyen TH; Roth S; Krumbholz R; Yao M; Richards B; Zhang M; Pechan P; Schmid S; Scaria A; Kaplan J; Teicher BA
Mol Cancer Ther; 2011 Mar; 10(3):404-15. PubMed ID: 21252283
[TBL] [Abstract][Full Text] [Related]
3. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
Björndahl M; Cao R; Eriksson A; Cao Y
Circ Res; 2004 Jun; 94(11):1443-50. PubMed ID: 15192038
[TBL] [Abstract][Full Text] [Related]
4. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
[TBL] [Abstract][Full Text] [Related]
6. Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer.
Chiron M; Bagley RG; Pollard J; Mankoo PK; Henry C; Vincent L; Geslin C; Baltes N; Bergstrom DA
Mol Cancer Ther; 2014 Jun; 13(6):1636-44. PubMed ID: 24688047
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
Krishnan B; Torti FM; Gallagher PE; Tallant EA
Prostate; 2013 Jan; 73(1):60-70. PubMed ID: 22644934
[TBL] [Abstract][Full Text] [Related]
8. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
9. VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.
Park I; Yang H; Park JS; Koh GY; Choi EK
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):609-618. PubMed ID: 30017791
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
[TBL] [Abstract][Full Text] [Related]
11. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
12. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.
Yang X; Zhang Y; Yang Y; Lim S; Cao Z; Rak J; Cao Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13932-7. PubMed ID: 23918367
[TBL] [Abstract][Full Text] [Related]
14. Placenta growth factor is a survival factor for human malignant mesothelioma cells.
Albonici L; Doldo E; Palumbo C; Orlandi A; Bei R; Pompeo E; Mineo TC; Modesti A; Manzari V
Int J Immunopathol Pharmacol; 2009; 22(2):389-401. PubMed ID: 19505392
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
[TBL] [Abstract][Full Text] [Related]
16. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
19. A fusion protein with the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A) is an antagonist of angiogenesis in cancer treatment: Simultaneous blocking of VEGF receptor-1 and 2.
Tseng FJ; Chen YC; Lin YL; Tsai NM; Lee RP; Chung YS; Chen CH; Liu YK; Huang YS; Hwang CH; Lai YK; Liao KW
Cancer Biol Ther; 2010 Nov; 10(9):865-73. PubMed ID: 20818186
[TBL] [Abstract][Full Text] [Related]
20. Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas.
Jiang H; Wu X; Wang H; Huang C; Zhang L
Cell Physiol Biochem; 2015; 36(3):930-6. PubMed ID: 26088746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]